Connection
Anthony Elias to Glycine
This is a "connection" page, showing publications Anthony Elias has written about Glycine.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.224 |
|
|
|
-
Tap WD, Cote GM, Burris H, Gore L, Elias A, Beeram M, Conley AP, Gianolio DA, Qu Z, Pandya S, Trent JC. Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Long-term Safety and Clinical Activity in Patients with Conventional Chondrosarcoma. Clin Cancer Res. 2025 Jun 03; 31(11):2108-2114.
Score: 0.224